Attached files

file filename
10-Q - 10-Q - AMARIN CORP PLC\UKamrn-10q_20200930.htm
EX-32.1 - EX-32.1 - AMARIN CORP PLC\UKamrn-ex321_7.htm
EX-31.2 - EX-31.2 - AMARIN CORP PLC\UKamrn-ex312_8.htm
EX-31.1 - EX-31.1 - AMARIN CORP PLC\UKamrn-ex311_6.htm
EX-10.8 - EX-10.8 - AMARIN CORP PLC\UKamrn-ex108_220.htm
EX-10.6 - EX-10.6 - AMARIN CORP PLC\UKamrn-ex106_247.htm
EX-10.5 - EX-10.5 - AMARIN CORP PLC\UKamrn-ex105_246.htm
EX-10.4 - EX-10.4 - AMARIN CORP PLC\UKamrn-ex104_245.htm
EX-10.3 - EX-10.3 - AMARIN CORP PLC\UKamrn-ex103_244.htm
EX-10.2 - EX-10.2 - AMARIN CORP PLC\UKamrn-ex102_243.htm

Exhibit 10.7

 

 

Renewal Agreement:

 

 

 

 

Agreement Date : 26 June 2020

Confirmation No : R-911513

 

 

Business Centre Details

 

Client Details

 

 

DUBLIN, Spaces South Docklands

 

Company Name

Amarin Pharmaceuticals Ireland Ltd

 

 

 

 

 

 

 

 

 

Phone

+353 87 833 5658

 

 

 

 

 

 

 

 

 

 

Email

tom.maher@amarincorp.com

 

 

 

 

 

 

 

 

Office Payment Details (exc. VAT and exc. services)

Office Number

Number of people

Price per Office

114

4

€ 2,115.60

 

 

Service Provision :

Start Date

1 October 2020

End Date

30 April 2021

 

All agreements end on the last calendar day of the month.

 

 

Terms and Conditions

 

 

 

We are Regus CME Ireland Limited [the Provider], please click the link below for terms and conditions.